Skip to content

The effect of short term intensive cognitive training using repetitive transcranial magnetic stimulation for mild cognitive impairment

The effect of short term intensive cognitive training using repetitive transcranial magnetic stimulation for mild cognitive impairment - The effect of intensive cognitive training using rTMS for MCI

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032220329
Enrollment
30
Registered
2022-09-12
Start date
2022-11-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild cognitive impairment forgetfullness, MCI

Interventions

Cognitive rehabilitation of 3 times per week during 2weeks, using computer training software for 40 minutes after repetitive transcranial magnetic stimulation (theta burst or sham stimulation) for 3mi
D015928, D050781
ognitive therapy, repetitive transcranial magnetic stimulation

Sponsors

Takakura Tomokazu
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Be aware of forgetfulness. 2.Housework and activities of daily living are generally normal. 3.Age more than or equal to 60 years and less tha 80 years. 4.Those who can go to the hospital according to the test protocol. 5.Written informed consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1.Under treatment for epilepsy/depression/mania/ schizophrenia. 2.Who have a cardiac pacemaker, implantable defibrillator, metal near the stimulation site (cochlear implant, magnetic clip, deep brain stimulation / vagus nerve stimulation), or implantable drug solution pump. 3. Severe heart disease:unstable angina,short-term myocardial infarction from onset, decompensated congestive heart failure, acute pulmonary heart, uncontrolled arrhythmia, severe aortic stenosis, active Myocarditis, endocarditis, etc. 4. Uncontrolled hypertension 5. Acute systemic illness or fever 6. Complications of recent pulmonary embolism, acute cor pulmonale, and severe pulmonary hypertension 7. Complication of severe hepatic / renal dysfunction 8. Severe orthopedic complications 9. Severe cognitive impairment (MMSE-J less tha or equal to 20/30), complications of severe mental illness 10. Other metabolic disorders (such as acute thyroiditis) 11. When using drugs that lower the threshold of spasm attacks (tricyclic antidepressants, maprotiline, theophylline, methylphenidate, ketamine, clozapine, zotepine) and abuse of alcohol, caffeine, stimulants, etc. 12. Lactating women 13. Other patients who are judged by the research-responsible (sharing) doctor to be inappropriate as research subjects.

Design outcomes

Primary

MeasureTime frame
MOCA-J total score after the intervention, amount of change from baseline

Secondary

MeasureTime frame
Scores after the intervention as below. 1.MOCAJ subitems (visual space-execution system, naming, attention, language, abstract concept, delayed reproduction, orientation) 2.Spatial working memory (PUME on RehaCom software) 3.Digit Span (number of forward spans) 4.Verbal working memory, Reading Span Test (span score) 5.Word Fluency Test (total number of recalls) 6.Electrophysiological evaluations, RMT, SAI (ISI grand mean from 21 to 25ms)

Contacts

Public ContactTomokazu Takakura

Juntendo Tokyo Koto Geriatric Medical Center

t-takakura@juntendo.ac.jp+81-3-5632-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026